Japan's Takeda Pharma to restructure after annual profit slump | Business Information & News | Westlaw

Japan's Takeda Pharma to restructure after annual profit slump | Business Information & News | Westlaw

View on Westlaw or start a FREE TRIAL today, Japan's Takeda Pharma to restructure after annual profit slump, Business Information & News
5/9/24 REUTERS 06:15:52
REUTERS
Copyright (c) 2024 Thomson Reuters
May 9, 2024
Japan's Takeda Pharma to restructure after annual profit slump
Stephen Coates
Rocky Swift
Christopher Cushing
TOKYO (Reuters) -Japan's Takeda Pharmaceutical announced a restructuring on Thursday after annual profit slid by more than half following the loss of patent protection of major sellers.
Japan's biggest drugmaker said it will incur restructuring costs...
---- Index References ----
Company: Takeda Pharmaceutical Company Limited
News Subject: (Health & Family (1HE30))
Industry: (Drug Approval Process (1DR91); Drug Discovery & Development Process (1DR41); Pharmaceuticals (1PH33); Pharmaceuticals & Biotechnology (1PH13); Pharmaceuticals & Biotechnology Industry Highlights (1PH07); Pharmaceuticals Research & Development (1PH57))
Region: (Asia (1AS61); Eastern Asia (1EA61); Far East (1FA27); Japan (1JA96))
Language: EN
Other Indexing: (Japan; Takeda Pharma)
Keywords: health; corpgov
Word Count: 308
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.